Insulet Corporation (PODD) stock forecast · P/E 34, rev $2.71B
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
This PODD forecast page states what the cached financials imply — not a price target and not a guarantee. Insulet Corporation outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported PODD revenue for 2025-12-31 was $2.71B. Net income was $247.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Period-over-period revenue change is not in cache for PODD, so this page does not invent a growth rate.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next PODD 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the PODD stock page.
Not investment advice.